We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · June 17, 2021

Dose-Escalated RT + Temozolomide Is Associated With Improved Survival in GBM

International Journal of Radiation Oncology, Biology, Physics


Additional Info

International Journal of Radiation Oncology, Biology, Physics
Dose Escalated Radiotherapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials
Int. J. Radiat. Oncol. Biol. Phys 2021 May 12;[EPub Ahead of Print], R Singh, EJ Lehrer, M Wang, HK Perlow, NG Zaorsky, DM Trifiletti, J Bovi, P Navarria, S Scoccianti, V Gondi, PD Brown, JD Palmer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading